Esomeprazole updated on 08-08-2023

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18813
R80050
Broe (Controls unexposed, general pop), 2025 Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) 1st trimester population based cohort retrospective unexposed (general population or NOS) excluded Adjustment: Yes 1.47 [1.10;1.95]
excluded (control group)
52/1,104   17,374/481,595 17,426 1,104
ref
S18817
R80051
Broe (Controls unexposed, sick), 2025 Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) 1st trimester population based cohort retrospective unexposed, sick Adjustment: Yes 1.07 [0.75;1.52] 52/1,104   127/2,773 179 1,104
ref
S14455
R57401
Choi a, 2023 Major congenital malformations 1st trimester retrospective cohort (claims database) unexposed, sick Adjustment: Yes 1.10 [1.02;1.20] 542/12,516   85,900/2,655,676 86,442 12,516
ref
S4412
R28450
Pasternak, 2010 Major birth defects (Exposure during First Trimester) 1st trimester population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes 1.19 [0.77;1.84] 23/668   21,867/837,317 21,890 668
ref
Total 3 studies 1.10 [1.02;1.19] 108,511 14,288
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Broe (Controls unexposed, sick), 2025Broe, 2025 1 1.07[0.75; 1.52]1791,1045%ROB confusion: seriousROB selection: moderateROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Choi a, 2023Choi a, 2023 1.10[1.02; 1.20]86,44212,51692%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: unclearROB mesure: NAROB reporting: NA Pasternak, 2010Pasternak, 2010 1.19[0.77; 1.84]21,8906683%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Total (3 studies) I2 = 0% 1.10[1.02; 1.19]108,51114,2880.55.01.0ROB: A: confounding, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.10[1.02; 1.19]108,51114,2880%NABroe (Controls unexposed, sick), 2025 Choi a, 2023 Pasternak, 2010 3 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.19[0.77; 1.84]21,890668 -NAPasternak, 2010 1 unexposed, sickunexposed, sick 1.10[1.01; 1.19]86,62113,6200%NABroe (Controls unexposed, sick), 2025 Choi a, 2023 2 Tags Adjustment   - Yes  - Yes 1.10[1.02; 1.19]108,51114,2880%NABroe (Controls unexposed, sick), 2025 Choi a, 2023 Pasternak, 2010 3 All studiesAll studies 1.10[1.02; 1.19]108,51114,2880%NABroe (Controls unexposed, sick), 2025 Choi a, 2023 Pasternak, 2010 30.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18813

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.38[1.09; 1.75]39,3161,7720%NABroe (Controls unexposed, general pop), 2025 Pasternak, 2010 2 unexposed, sick controlsunexposed, sick controls 1.10[1.01; 1.19]86,62113,6200%NABroe (Controls unexposed, sick), 2025 Choi a, 2023 20.510.01.0